|
| |
|
|
| |
|
|
2008 iBio
(May 18-22, 2008,Hangzhou,China)
|
|
|
|
|
|
|
|
|
|
|
|
|
CEMD-2008
(
Oct.22-28, 2008, Beijing & Xi'an, China )
|
|
|
WCV 2008
( Dec.1-5, 2008, Guangzhou, China) |
|
|
|
|
|
|
WCG 2008
(Dec. 5-7, 2008, Guangzhou, China)
|
|
|
|
|
|
| |
|
|
|
|
|
| |
| Track 3: Drug Discovery Technologies |
| -Speeding Discovery Process with Niches |
| |
| Session 26: RNAi, MicroRNA, and Non-Coding RNA Technologies |
| Session 27: Bioinformatics, Bio-IT, LIMS to Data Visualization in Drug Discovery |
| Session 28: Computer Aided Drug Design and Fragment-Based Discovery |
| Session 29: Multiple Read-Out Options, Biochips, Microarray, Electrophoresis, Lab-on-Chips and Lab Automation |
| Session 30: High Throughput/Content and Virtual Screening |
| Session 31: Technologies from Enzyme to Cell Based Assays |
| Session 32: Translational Medicines |
| Session 33: LC, LC-MS, NMR and X-ray Crystallography in Drug Discovery |
| Session 34: Safety Evaluation Tech: From ADME-Tox Screening to Clinical Trials |
| Session 35: Nanotechnologies and Novel Drug Delivery Technologies |
|
| |
| |
| |
| |
| |
|
|
| BIT's Claims: All events BIT Life Sciences organized are purely for promotion of advancement of sciences and technologies for the sustainable development of a healthier and wealthier world. No political, religious racial bias and non-ethic knowledge are accepted through our intelligence exchange platform. Any illegal and offensive Information will be 100% avoided. |
|
|
